ArticleLupus2024

Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark.

Anne Troldborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.